Navigation Links
Smith & Nephew Announces Breakthrough VERILAST(TM) Technology
Date:3/4/2008

Studies show a stronger and longer lasting knee

MEMPHIS, Tenn. and SAN FRANCISCO, March 4 /PRNewswire-FirstCall/ -- Smith & Nephew, Inc. (NYSE: SNN, LSE: SN) Orthopaedic Reconstruction business today announced the introduction of its VERILAST(TM) Technology. VERILAST Technology represents a technological leap forward in implant performance for knee replacement surgery. VERILAST Technology is an optimized material combination engineered specifically to improve knee implant performance and durability. This technology combines Smith & Nephew's award winning OXINIUM(TM) material with highly cross-linked polyethylene (XLPE) to produce a one-of-a-kind total knee replacement device.

"Smith & Nephew has a longstanding reputation for providing surgeons with innovative technologies designed to maximize patient outcomes," said Joseph DeVivo, president of Smith & Nephew Orthopaedic Reconstruction. "Initial data on implant wear compared to competitive systems has been very encouraging. Due to the significant improvements we are observing in wear rates over competitive material combinations, a knee with VERILAST Technology may be the only implant many patients ever receive. Combined with our award-winning OXINIUM Oxidized Zirconium, the history of innovation in implant endurance continues with the introduction of our VERILAST Technology."

In lab testing, Smith & Nephew researchers demonstrated that the composition of both articulating surfaces is critical to the performance of the entire bearing couple. When XLPE is combined with OXINIUM alloy, significant improvements in wear resistance are both provided and maintained. Smith & Nephew is the only orthopaedic manufacturer that utilizes high performance materials in both be
'/>"/>

SOURCE Smith & Nephew, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
2. GlaxoSmithKline Responds to JAMA Articles
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
5. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
6. TIGroup Names Dennis M. Smith as Chief Financial Officer
7. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
8. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
9. Smith & Nephew Endoscopys KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries
10. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
11. Smithfield(R) LEAN GENERATION(R) Announces DELI FOR THE CURE(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...m workers are three times as likely as all other c...hildren to be uninsured, according to a report in ...lescent Medicine, one of the JAMA/Archives journal...health challenges, according to background informa... already has suboptimal access to pediatric health...
(Date:12/2/2008)...asylol have a higher death risk, data review finds...- A new study casts more doubt on the safety of th...g in patients undergoing surgery. , Trasylol is...States, where it was removed from the market in 20... researchers reviewed findings from 49 randomized ...
(Date:12/2/2008)...or Tuesday, December 2, 2008 at 3 pm CST)--Radiolo... University of South Carolina in Charleston, S.C.,...cer from exposure to radiation during computed tom...ated and that new estimates are several times lowe... researchers presented their findings at the annu...
(Date:12/2/2008)...PRNewswire-FirstCall/ -- United American Healthcar...rovides comprehensive healthcare,management servi...oday,announced that its Board of Directors has ap...e Company to repurchase up to $1.0 million of its ...lows for the Company,s common shares to be purchas...
Breaking Medicine News(10 mins):Health News:1/3 of farm workers' children lack health insurance 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2
...al food market is estimated at around $2.5 trillio...of four percent per annum. A radical shift in food...over. In markets, especially in the developed wor...the consumption of healthier foods is rapidly incr...
...test that detects proteins commonly released by a ...or monitoring the effectiveness of chemotherapy a...oat cancer, according to a study published in the ...er Research. Scientists in the National Institute...
...ers have found that patients with obstructive slee...d cells (apoptotic cells) from the lining (endothe...bloodstream than people who do not have OSA. The f...th OSA are at higher risk for cardiovascular disea...
...rospective study of 700 patients with culture-posi...o be significantly higher in HIV-infected patient...rifamycin-based regimen. Furthermore, TB relapse r...eived intermittent or standard 6-month therapy whe...
Other Medicine News:Health News:Nutrient-rich Dairy Beverages an Emerging Market 2Health News:Blood Test may Help Signal Tumor's Remission, Return in Throat Cancer Patients 2Health News:Blood Test may Help Signal Tumor's Remission, Return in Throat Cancer Patients 3Health News:Blood Test may Help Signal Tumor's Remission, Return in Throat Cancer Patients 4Health News:Patients With OSA at Higher Risk for Cardiovascular Disease 2Health News:Patients With OSA at Higher Risk for Cardiovascular Disease 3Health News:Treatment Outcomes of Patients With HIV and Tuberculosis 2
(Date:12/2/2008)..., Kan., Dec. 2 IBT Laboratories, a...arch laboratory specializing in immunology and all...ests to evaluate the response of patients whose i...immunodeficiency disorder, chemotherapy drugs, or ...o prevent rejection of a transplant. The company l...
(Date:12/1/2008)...O, Dec. 2 New research ...t-slice computed tomography (CT) scanner in an eme...of stroke victims who receive a potentially life-s...t North Shore Medical Center (NSMC)-Salem Hospital...nnual meeting of the Radiological Society of North...
(Date:12/1/2008)...ORE, Dec. 1 S*BIO Pte Ltd today an...al of SB1518, a potent and orally-active JAK2 inhi... patients with chronic idiopathic myelofibrosis (C...e the safety and tolerability of SB1518 in patient...ents. The Phase 1 part of the study will assess t...
(Date:12/1/2008)...Abstinence is still the best policy , , RO...A new study from Mayo Clinic finds the use of the ...coholic hepatitis, an acute inflammation of the li...e results of the study are published in the Decemb...journal.org/ ). , , VIDEO ALERT: Additiona...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3China Pharma Holdings Inc to Host Second Quarter 2008 Earnings Conference Call at 10 a m EDT Wednesday August 6 2008 6877 1China Pharma Holdings Inc to Host Second Quarter 2008 Earnings Conference Call at 10 a m EDT Wednesday August 6 2008 6877 2Strategies to control TB outdated inadequate 24851 1Strategies to control TB outdated inadequate 24851 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 1Immune system protein accurate predictor of survival in pediatric septic shock 4305 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 3HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 1HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 2HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power 26apos 3Bs Employee Health and Wellness Initiative New Issu 24849 3
...Sciences, Inc.,(Nasdaq:GILD) today announced detai...ing aztreonam lysine for inhalation, an,antibiotic...ulmonary Pseudomonas aeruginosa (P. aeruginosa). I...m lysine significantly improved,the time to need f...placebo. All patients received an initial 28 days ...
...x Pharmaceuticals,Inc. (OTCBB:CGXP), a biopharmac...dermatology, today announced the publication,of a ...al,compounds: CSA-8 and CSA-13. The paper appeared...l Agents and Chemotherapy, a,peer-reviewed officia... dedicated to advances in the field of applied,mic...
Other Medicine Technology:Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
VERSASTEP™ Reposable Short Single-Use For use with VERSASTEP™ Short Reusable Cannula, Dilator.
VersaStep™ Reposable Sterilization Trays.
VERSASTEP™ Plus Long Instrument for applications in laparoscopic procedures., ,The VERSASTEP™ Plus Long Instrument with 150mm Working Length is a unique endoscopic entry device that has
...ade; Blunt Tip Trocar consists of a blunt obturato... , ,The valve body assembly contains an internal ... instruments are inserted or withdrawn. The Autosu...verters to allow insertion of instruments of diffe...
Medicine Products: